Herantis Pharma Oyj
HEL:HRTIS.HE
1.69 (EUR) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | 2013 Q4 | 2013 Q2 | 2012 Q4 | 2012 Q2 | 2011 Q4 | 2011 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.051 | 0 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | -0.08 | 0.464 | 0.464 | 0.484 | 0.562 | 0 | 0 | 1.213 | 0 | 0.604 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | -0.08 | 0.08 | -0.464 | -0.464 | -0.484 | -0.562 | 0 | 0 | 0 | 0 | 0 | 0.025 | 0 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 2.1 | 0.6 | 1.5 | 2.12 | 2.88 | 2.96 | 3.24 | 3.028 | 2.3 | 1.764 | 0.7 | 1.928 | 1.1 | 1.628 | 0.7 | 0.764 | 1.2 | 4.976 | 4.1 | 3.819 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.846 | 0.766 | 0.442 | 1.188 | 1.488 | 1.64 | 0.481 | 2.369 | 1.495 | 1.339 | 0.328 | 2.476 | 0.562 | 0.682 | 0.449 | 0.575 | 0.643 | 0.545 | 0.283 | 0.766 | 0.76 | 0 | 0.054 | 106.7 | 0.191 | 0.191 | 0.716 | 0.716 |
| Other Expenses
| -0.575 | -0.11 | -2.323 | 0.28 | 0.169 | 0.003 | 0 | 1.295 | 0.299 | 0.411 | 0.023 | 0.113 | -0.133 | 0.235 | -0.134 | 0.15 | 0 | 0 | -4.041 | 8.866 | 1.437 | 1.194 | 0.203 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 2.271 | 2.756 | -2.562 | 2.408 | 3.473 | 4.52 | 4.51 | 4.54 | 4.523 | 3.549 | 3.745 | 2.364 | 2.356 | 2.514 | 0.898 | 2.002 | 1.243 | 2.4 | 2.436 | 13.732 | 6.015 | 1.194 | 0.257 | 0.312 | 0.191 | 0.191 | 0.719 | 0.719 |
| Operating Income
| -2.271 | -2.756 | 2.562 | -2.408 | -3.473 | -4.52 | -4.59 | -4.46 | -4.059 | -4.013 | -4.229 | -2.926 | -2.356 | -2.514 | -1.942 | -2.002 | -1.847 | -2.573 | -2.436 | -13.731 | -6.015 | -1.194 | -0.257 | -0.312 | -0.19 | -0.19 | -0.737 | -0.737 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.865 | -6,089.191 | -11,898.244 | -7,518.308 | 0 | 0 | 0 | -8,648.907 | -8,648.907 | 0 | 0 |
| Total Other Income Expenses Net
| 0.018 | 0.069 | -0.487 | -0.591 | -0.2 | -1.131 | -0.239 | -0.067 | -0.622 | -0.459 | -0.456 | -0.393 | -0.059 | 0.75 | 1.806 | -0.025 | 0.02 | -0.025 | -0.024 | 0.145 | 0.103 | -0.796 | -0.009 | -0.01 | -0.007 | -0.007 | 0.014 | 0.014 |
| Income Before Tax
| -2.253 | -2.687 | 2.075 | -1.795 | -3.673 | -5.651 | -4.829 | -7.938 | -4.681 | -4.472 | -4.686 | -3.319 | -2.415 | -1.765 | -0.137 | -2.028 | -1.827 | -2.597 | -2.459 | -13.585 | -5.911 | -1.99 | -0.266 | -0.322 | -0.197 | -0.197 | -0.723 | -0.723 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -51.352 | -6,148.711 | -11,772.267 | -7,389.03 | 0 | 0 | 0 | -8,963.872 | -8,963.872 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.243 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.059 | 0 | 0 | -0.025 | 0 | -0.025 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| Net Income
| -2.253 | -2.687 | 1.037 | -0.898 | -1.83 | -2.833 | -2.414 | -21.162 | -6.917 | -2.236 | -2.343 | -1.659 | -2.415 | -1.765 | -0.137 | -2.028 | -1.827 | -2.597 | -2.459 | -13.585 | -5.911 | -1.99 | -0.266 | -0.322 | -0.197 | -0.197 | -0.723 | -0.723 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -51.352 | -6,148.711 | -11,772.267 | -7,389.03 | 0 | 0 | 0 | -8,963.918 | -8,963.918 | 0 | 0 |
| EPS
| -0.11 | -0.133 | 0.059 | -0.053 | -0.11 | -0.23 | -0.22 | -1.977 | -0.87 | -0.31 | -0.36 | -0.28 | -0.46 | -0.34 | -0.03 | -0.46 | -0.419 | -0.64 | -0.6 | -3.34 | -1.44 | -0.76 | -0.22 | -0.53 | -35.58 | -35.58 | -130.76 | -130.76 |
| EPS Diluted
| -0.11 | -0.133 | 0.059 | -0.053 | -0.11 | -0.23 | -0.22 | -1.977 | -0.87 | -0.31 | -0.36 | -0.28 | -0.46 | -0.34 | -0.03 | -0.46 | -0.419 | -0.64 | -0.6 | -3.34 | -1.44 | -0.76 | -0.22 | -0.26 | -0.16 | -0.16 | -0.59 | -0.59 |
| EBITDA
| -2.252 | -5.364 | 1.317 | -0.563 | -3.472 | -4.52 | -4.508 | 11.429 | -3.58 | -3.564 | -3.744 | -2.345 | -1.755 | -2.269 | 1.44 | -1.391 | -1.198 | -1.947 | -1.601 | -5.137 | -5.204 | -0.814 | -0.236 | -0.236 | -0.169 | -0.169 | -0.698 | -0.698 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -38.489 | -4,003.59 | -4,451.761 | -6,505.505 | 0 | 0 | 0 | -7,711.8 | -7,711.8 | 0 | 0 |